AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 1-25/56
EC-SOD gene therapy reduces paracetamol-induced liver damage in mice
Authors: Laukkanen, MO Leppanen, P Turunen, P Tuomisto, T Naarala, J Yla-Herttuala, S
Citation: Mo. Laukkanen et al., EC-SOD gene therapy reduces paracetamol-induced liver damage in mice, J GENE MED, 3(4), 2001, pp. 321-325
Optimized in situ PCR method for the detection of gene transfer vector in histological sections
Authors: Leppanen, PM Koponen, J Turunen, MP Pakkanen, T Yla-Herttuala, S
Citation: Pm. Leppanen et al., Optimized in situ PCR method for the detection of gene transfer vector in histological sections, J GENE MED, 3(2), 2001, pp. 173-178
Extracellular superoxide dismutase deficiency and atherosclerosis in mice
Authors: Sentman, ML Brannstrom, T Westerlund, S Laukkanen, MO Yla-Herttuala, S Basu, S Marklund, SL
Citation: Ml. Sentman et al., Extracellular superoxide dismutase deficiency and atherosclerosis in mice, ART THROM V, 21(9), 2001, pp. 1477-1482
Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries
Authors: Brasen, JH Kivela, A Roser, K Rissanen, TT Niemi, M Luft, FC Donath, K Yla-Herttuala, S
Citation: Jh. Brasen et al., Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries, ART THROM V, 21(11), 2001, pp. 1720-1726
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3
Authors: Makinen, T Jussila, L Veikkola, T Karpanen, T Kettunen, MI Pulkkanen, KJ Kauppinen, R Jackson, DG Kubo, H Nishikawa, SI Yla-Herttuala, S Alitalo, K
Citation: T. Makinen et al., Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3, NAT MED, 7(2), 2001, pp. 199-205
Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes
Authors: Heikkila, A Hiltunen, MO Turunen, MP Keski-Nisula, L Turunen, AM Rasanen, H Rissanen, TT Kosma, VM Manninen, H Heinonen, S Yla-Herttuala, S
Citation: A. Heikkila et al., Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes, GENE THER, 8(10), 2001, pp. 784-788
Gene therapy for coronary heart disease
Authors: Yla-Herttuala, S
Citation: S. Yla-herttuala, Gene therapy for coronary heart disease, J INTERN M, 250(5), 2001, pp. 367-368
HSV-tk gene therapy for human renal cell carcinoma in nude mice
Authors: Pulkkanen, KJ Parkkinen, JJ Laukkanen, JM Kettunen, MI Tyynela, K Kauppinen, RA Ala-Opas, MY Yla-Herttuala, S
Citation: Kj. Pulkkanen et al., HSV-tk gene therapy for human renal cell carcinoma in nude mice, CANC GENE T, 8(7), 2001, pp. 529-536
Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL
Authors: Narvanen, O Erkkila, A Yla-Herttuala, S
Citation: O. Narvanen et al., Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL, FREE RAD B, 31(6), 2001, pp. 769-777
A model for gene therapy of human hereditary lymphedema
Authors: Karkkainen, MJ Saaristo, A Jussila, L Karila, KA Lawrence, EC Pajusola, K Bueler, H Eichmann, A Kauppinen, R Kettunen, MI Yla-Herttuala, S Finegold, DN Ferrell, RE Alitalo, K
Citation: Mj. Karkkainen et al., A model for gene therapy of human hereditary lymphedema, P NAS US, 98(22), 2001, pp. 12677-12682
Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions
Authors: Heydeck, D Upston, JM Viita, H Yla-Herttuala, S Stocker, R
Citation: D. Heydeck et al., Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions, J LIPID RES, 42(7), 2001, pp. 1082-1088
Rabbit atherosclerotic lesions express scavenger receptor AIII mRNA, a naturally occurring splice variant that encodes a non-functional, dominant negative form of the macrophage scavenger receptor
Authors: Hiltunen, TP Gough, PJ Greaves, DR Gordon, S Yla-Herttuala, S
Citation: Tp. Hiltunen et al., Rabbit atherosclerotic lesions express scavenger receptor AIII mRNA, a naturally occurring splice variant that encodes a non-functional, dominant negative form of the macrophage scavenger receptor, ATHEROSCLER, 154(2), 2001, pp. 415-419
Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic
Authors: Rissanen, TT Vajanto, I Yla-Herttuala, S
Citation: Tt. Rissanen et al., Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic, EUR J CL IN, 31(8), 2001, pp. 651-666
Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin
Authors: Enholm, B Karpanen, T Jeltsch, M Kubo, H Stenback, F Prevo, R Jackson, DG Yla-Herttuala, S Alitalo, K
Citation: B. Enholm et al., Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin, CIRCUL RES, 88(6), 2001, pp. 623-629
Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth
Authors: Karpanen, T Egeblad, M Karkkainen, MJ Kubo, H Yla-Herttuala, S Jaattela, M Alitalo, K
Citation: T. Karpanen et al., Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth, CANCER RES, 61(5), 2001, pp. 1786-1790
Gene therapy for dyslipidaemias
Authors: Pakkanen, T Yla-Herttuala, S
Citation: T. Pakkanen et S. Yla-herttuala, Gene therapy for dyslipidaemias, EUR H J SUP, 2(D), 2000, pp. D62-D64
False-positive apoptosis signal in mouse kidney and liver detected with TUNEL assay
Authors: Pulkkanen, KJ Laukkanen, MO Naarala, J Yla-Herttuala, S
Citation: Kj. Pulkkanen et al., False-positive apoptosis signal in mouse kidney and liver detected with TUNEL assay, APOPTOSIS, 5(4), 2000, pp. 329-333
Insights into the molecular pathogenesis of atherosclerosis and therapeutic strategies using gene transfer
Authors: Hiltunen, MO Turunen, MP Laitinen, M Yla-Herttuala, S
Citation: Mo. Hiltunen et al., Insights into the molecular pathogenesis of atherosclerosis and therapeutic strategies using gene transfer, VASC MED, 5(1), 2000, pp. 41-48
Periadventitial lacZ gene transfer to pig carotid arteries using a biodegradable collagen collar or a wrap of collagen sheet with adenoviruses and plasmid-liposome complexes
Authors: Pakkanen, TM Laitinen, M Hippelainen, M Hiltunen, MO Alhava, E Yla-Herttuala, S
Citation: Tm. Pakkanen et al., Periadventitial lacZ gene transfer to pig carotid arteries using a biodegradable collagen collar or a wrap of collagen sheet with adenoviruses and plasmid-liposome complexes, J GENE MED, 2(1), 2000, pp. 52-60
Vascular protection - A novel nonangiogenic cardiovascular role for vascular endothelial growth factor
Authors: Zachary, I Mathur, A Yla-Herttuala, S Martin, J
Citation: I. Zachary et al., Vascular protection - A novel nonangiogenic cardiovascular role for vascular endothelial growth factor, ART THROM V, 20(6), 2000, pp. 1512-1520
Retrovirus-mediated, stable scavenger-receptor gene transfer leads to functional endocytotic receptor expression, foam cell formation, and increased susceptibility to apoptosis in rabbit aortic smooth muscle cells
Authors: Lehtolainen, P Takeya, M Yla-Herttuala, S
Citation: P. Lehtolainen et al., Retrovirus-mediated, stable scavenger-receptor gene transfer leads to functional endocytotic receptor expression, foam cell formation, and increased susceptibility to apoptosis in rabbit aortic smooth muscle cells, ART THROM V, 20(1), 2000, pp. 52-60
Autoantibodies against oxidized low-density lipoprotein and cardiolipin inpatients with coronary heart disease
Authors: Erkkila, AT Narvanen, O Lehto, S Uusitupa, MIJ Yla-Herttuala, S
Citation: At. Erkkila et al., Autoantibodies against oxidized low-density lipoprotein and cardiolipin inpatients with coronary heart disease, ART THROM V, 20(1), 2000, pp. 204-209
Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty
Authors: Laitinen, M Hartikainen, J Hiltunen, MO Eranen, J Kiviniemi, M Narvanen, O Makinen, K Manninen, H Syvanne, M Martin, JF Laakso, M Yla-Herttuala, S
Citation: M. Laitinen et al., Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty, HUM GENE TH, 11(2), 2000, pp. 263-270
Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses
Authors: Sandmair, AM Loimas, S Puranen, P Immonen, A Kossila, M Puranen, M Hurskainen, H Tyynela, K Turunen, M Vanninen, R Lehtolainen, P Paljarvi, L Johansson, R Vapalahti, M Yla-Herttuala, S
Citation: Am. Sandmair et al., Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses, HUM GENE TH, 11(16), 2000, pp. 2197-2205
Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery
Authors: Airenne, KJ Hiltunen, MO Turunen, MP Turunen, AM Laitinen, OH Kulomaa, MS Yla-Herttuala, S
Citation: Kj. Airenne et al., Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery, GENE THER, 7(17), 2000, pp. 1499-1504
Risultati: 1-25 | 26-50 | 51-56